Researchers in the Netherlands are making progress toward potential treatments for a rare neurological condition linked to consuming contaminated shellfish from the North Sea, using lab-grown mini-brains to study the disease’s effects on human neural tissue. The approach, which involves cultivating cerebral organoids from human stem cells, allows scientists to observe how the toxin responsible for the illness interacts with developing brain cells in a controlled environment. This method offers a significant advance over traditional animal models, which often fail to fully replicate the complex pathology seen in human patients.
The condition in question, known as domoic acid poisoning or amnesic shellfish poisoning (ASP), arises when individuals ingest shellfish that have accumulated the neurotoxin domoic acid produced by certain algal blooms. While outbreaks are infrequent, they can lead to severe and long-lasting neurological symptoms, including short-term memory loss, confusion, seizures and in extreme cases, coma or death. There is currently no specific antidote, and treatment remains limited to supportive care, making the development of targeted therapies a critical public health goal.
Recent operate by a team at the Erasmus Medical Center in Rotterdam has demonstrated that cerebral organoids exposed to domoic acid show measurable signs of neuronal stress and calcium dysregulation — key early indicators of neurotoxicity. These changes mirror those observed in clinical cases of ASP, validating the organoid model as a reliable tool for screening potential neuroprotective compounds. The researchers reported that certain candidate drugs, including analogs of existing anticonvulsants, were able to mitigate calcium influx and reduce cell death in the organoids, suggesting a pathway for future therapeutic intervention.
“Using mini-brains gives us a human-relevant system to study how this toxin disrupts neural function at the cellular level,” said Dr. Liesbeth van der Vliet, a neurologist involved in the project. “We can now test whether experimental compounds protect neurons before moving to more complex models — saving time, reducing reliance on animal testing, and increasing the chances of finding something that actually works in people.” Her comments were made during a presentation at the Dutch Society for Neuroscience annual meeting in Utrecht in November 2023, where preliminary data from the organoid studies were shared.
The North Sea has seen periodic blooms of Pseudo-nitzschia, the diatom genus responsible for producing domoic acid, particularly in coastal waters off the Netherlands, Denmark, and the United Kingdom. Monitoring programs run by Rijkswaterstaat, the Dutch government agency responsible for water infrastructure and environmental safety, regularly test shellfish harvesting zones for toxin levels. When concentrations exceed the European Union’s regulatory limit of 20 milligrams of domoic acid per kilogram of shellfish meat, affected areas are temporarily closed to commercial and recreational harvesting.
In 2022, a temporary closure was issued for parts of the Zeeland coastline after mussel samples tested just above the safety threshold — an event that prompted renewed attention to surveillance and response protocols. While no human cases were reported during that incident, public health officials emphasized the importance of early detection systems to prevent exposure. The European Food Safety Authority (EFSA) maintains that strict monitoring has kept the incidence of ASP highly low in Europe, with fewer than ten confirmed cases reported across the EU since 2000.
Despite its rarity, the potential severity of domoic acid poisoning has driven interest in better understanding its mechanisms. The toxin acts by overactivating glutamate receptors in the brain, leading to an excessive influx of calcium ions into neurons — a process known as excitotoxicity. This cascade can ultimately trigger cell death, particularly in the hippocampus, a region critical for memory formation, which explains the amnesia often seen in ASP patients. The cerebral organoid model allows researchers to visualize this process in real time using fluorescent calcium indicators, providing insights that are difficult to obtain from post-mortem tissue or animal studies alone.
Beyond drug screening, the organoid platform is being used to investigate whether genetic variations might influence individual susceptibility to domoic acid toxicity. Preliminary analyses suggest that differences in glutamate receptor subunit expression could affect how strongly neurons respond to the toxin, potentially explaining why some individuals experience more severe symptoms than others even after similar exposure levels. This line of inquiry could one day inform personalized risk assessments for populations that rely heavily on shellfish consumption, such as certain coastal communities.
The research is supported by funding from the Netherlands Organisation for Scientific Research (NWO) and aligns with broader efforts to develop human-based models for neurotoxicology screening. Similar organoid approaches have been applied to study other marine toxins, including brevetoxins from red tide events and ciguatera toxin associated with tropical reef fish, highlighting a growing trend toward using stem cell-derived systems to assess environmental health risks.
While the translation of organoid findings into approved therapies remains years away, experts view this work as a foundational step. “We’re not at the stage of clinical trials yet,” noted Dr. Van der Vliet, “but we are building the evidence base needed to justify them. Every compound we test in the mini-brains brings us closer to identifying a candidate that could one day be given to someone showing early signs of poisoning — potentially preventing long-term damage.”
Public health authorities continue to emphasize prevention through monitoring and public advisories as the primary defense against shellfish poisoning. The Netherlands Food and Consumer Product Safety Authority (NVWA) issues regular updates on shellfish safety via its website and collaborates with local health services to disseminate information during algal bloom events. Consumers are advised to only consume shellfish from approved sources and to avoid harvesting their own from recreational areas without checking current safety status.
As harmful algal blooms may become more frequent due to rising sea temperatures and nutrient runoff — factors linked to climate change — the require for effective surveillance and medical countermeasures is expected to grow. Researchers involved in the mini-brain project say their model could be adapted to study other emerging marine neurotoxins, offering a flexible platform for preparedness.
The next step for the Erasmus team involves validating their findings in more complex neural organoid models that include vascular and microglial components, which could better mimic the brain’s immune response and blood-brain barrier interactions. They also plan to publish their full dataset in a peer-reviewed journal later in 2024, which would allow independent replication and further scrutiny of their methods.
For now, the use of mini-brains to study a rare but serious North Sea-linked illness represents a convergence of regenerative medicine, toxicology, and public health innovation — one that may ultimately improve outcomes for those affected by marine neurotoxins, however uncommon their exposure may be.
Stay informed about shellfish safety alerts and marine toxin monitoring by checking updates from official sources such as the NVWA and EFSA. Share this article to support raise awareness about rare but important health risks tied to our oceans.